Found: 25
Select item for more details and to access through your institution.
Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells.
- Published in:
- Cell Biology International, 2010, v. 34, n. 7, p. 709, doi. 10.1042/CBI20090473
- By:
- Publication type:
- Article
A Review on the Association between Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer.
- Published in:
- Experimental Diabetes Research, 2012, p. 1, doi. 10.1155/2012/924168
- By:
- Publication type:
- Article
Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Diabetes mellitus impairs circulating proangiogenic granulocytes.
- Published in:
- Diabetologia, 2020, v. 63, n. 9, p. 1872, doi. 10.1007/s00125-020-05142-3
- By:
- Publication type:
- Article
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans.
- Published in:
- Diabetologia, 2015, v. 58, n. 10, p. 2352, doi. 10.1007/s00125-015-3667-8
- By:
- Publication type:
- Article
The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients.
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1475-2840-13-92
- By:
- Publication type:
- Article
Circulating myeloid calcifying cells have antiangiogenic activity via thrombospondin-1 overexpression.
- Published in:
- FASEB Journal, 2013, v. 27, n. 11, p. 4355, doi. 10.1096/fj.12-223719
- By:
- Publication type:
- Article
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 6, p. 593, doi. 10.1007/s00592-018-1129-8
- By:
- Publication type:
- Article
NETosis is induced by high glucose and associated with type 2 diabetes.
- Published in:
- Acta Diabetologica, 2015, v. 52, n. 3, p. 497, doi. 10.1007/s00592-014-0676-x
- By:
- Publication type:
- Article
Effects of Age, Diabetes, and Vascular Disease on Growth Differentiation Factor 11: First-in-Human Study.
- Published in:
- Diabetes Care, 2015, v. 38, n. 8, p. e118, doi. 10.2337/dc15-0868
- By:
- Publication type:
- Article
Endothelial dysfunction in diabetes: the role of reparatory mechanisms.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Endothelial Dysfunction in Diabetes.
- Published in:
- Diabetes Care, 2011, v. 34, p. S285, doi. 10.2337/dc11-s239
- By:
- Publication type:
- Article
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2010, v. 33, n. 7, p. 1607, doi. 10.2337/dc10-0187
- By:
- Publication type:
- Article
Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression.
- Published in:
- Basic Research in Cardiology, 2013, v. 108, n. 4, p. 1, doi. 10.1007/s00395-013-0368-7
- By:
- Publication type:
- Article
Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy.
- Published in:
- Basic Research in Cardiology, 2013, v. 108, n. 1, p. 1, doi. 10.1007/s00395-012-0313-1
- By:
- Publication type:
- Article
Endothelial progenitor cells in diabetes mellitus.
- Published in:
- Biofactors, 2012, v. 38, n. 3, p. 194, doi. 10.1002/biof.1016
- By:
- Publication type:
- Article
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway.
- Published in:
- Diabetes, 2019, v. 68, n. 6, p. 1303, doi. 10.2337/db19-0080
- By:
- Publication type:
- Article
Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway.
- Published in:
- 2019
- By:
- Publication type:
- journal article
NETosis Delays Diabetic Wound Healing in Mice and Humans.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor.
- Published in:
- Diabetes, 2015, v. 64, n. 8, p. 2969, doi. 10.2337/db15-0077
- By:
- Publication type:
- Article
Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M.
- Published in:
- Diabetes, 2015, v. 64, n. 8, p. 2957, doi. 10.2337/db14-1473
- By:
- Publication type:
- Article
Diabetes Causes Bone Marrow Autonomic Neuropathy and Impairs Stem Cell Mobilization via Dysregulated p66Shc and Sirt1.
- Published in:
- Diabetes, 2014, v. 63, n. 4, p. 1353, doi. 10.2337/db13-0894
- By:
- Publication type:
- Article
The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing.
- Published in:
- Diabetes, 2010, v. 59, n. 9, p. 2306, doi. 10.2337/db09-1727
- By:
- Publication type:
- Article